On March 6th, before market open, Wi-LAN (TSX:WIN) will report its fourth quarter and full year results for fiscal 2012.
After a Q3 that was regarded as mixed, management said it expects revenue to be at least $20.7 million, excluding the potential impact of any additional royalty agreements.
The Ottawa-patent player’s stock, meanwhile, has languished. After spiking to more than $9 midway through 2011, shares of Wi-LAN have slowly trailed off to current levels near the $4 mark.
Industrial Alliance Securities analyst Al Nagaraj says 2013 should be a much more active year for Wi-LAN than last year was. He notes that the company has an active docket of legal actions against vendors such as Apple, Dell, Sierra Wireless, HP, Alcatel and Ericsson. Because Wi-LAN has key patents in CDMA, Digital TV and WiFi, he expects a lot of success in these cases, which will he expects will boost revenue and EBITDA. In a research update to clients this morning, Nagaraj reiterated his BUY recommendation and $7.70 target on Wi-LAN.
___________________________________________________________________________________________________________
This article is brought to you by Zecotek (TSXV:ZMS). Zecotek holds over 50 patents and has launched a major U.S. patent infringement case. Click here to learn more.
_____________________________________________________________________________________________________________
Because of the absence of upfront fees from major licensing deals, Nagaraj isn’t expecting much from Wi-LAN’s Q4. He thinks the company’s topline will come in at $20-million, down 19.4% from the same period last year, and less than the consensus estimate of $22-million. He thinks gross margins will fall to 64% from last year’s 74%, for the same reason.
Nagaraj’s says his valuation is based on excess cash and 10x his 2014 EBITDA forecast of $97-million.
_______________________________________________________________________________________________________________
__________________________________________________________________________________________________________________
Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]
Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]
The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]
Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]
He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]
Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]